Page URL: https://www.bionews.org.uk/page_91023

Discovery of gene defect in mice will help allergy research

14 April 2009
Appeared in BioNews 503

Scientists in Scotland, Ireland and Japan have found a genetic defect in mice that mimics inflammation seen in allergic diseases such as eczema. The defect in the filaggrin gene could be used in research to further understand these diseases.

Eczema is inflammation of the skin, which causes itching and irritation, and often leads to other allergic conditions such as asthma. Eczema affects one in five children in the UK and other western nations, but the incidence of these allergic conditions has risen sharply over the last decade, most likely due to unknown environmental factors.

The fillagrin gene produces a protein in the outer layers of the skin that helps it produce a protective barrier. This barrier stops allergens entering the body and causing eczema and asthma, as well as hay fever and other allergies, and also prevents water loss to keep the skin hydrated. A mutation in the filaggrin gene affects the integrity of the barrier, thereby making the skin more permeable to allergens and causing allergic reactions.

Previous work has suggested that about half of severe cases of eczema in children were caused by defects in the filaggrin gene. The gene defect is carried by 10 per cent of the population.

This new research, published online in the journal Nature Genetics, shows that mice with the gene defect had allergic inflammation comparable to the human conditions. Professor Irwin McLean from the University of Dundee, who lead the research, says that 'the filaggrin-deficient mice will allow us to identify key substances in the environment responsible for the huge increase in allergic disease. These mice also represent a key to unlock new and improved therapies for eczema, asthma and allergies by targeting or supplementing the defective filaggrin gene'.

The hope that the findings can be used to develop treatments for the diseases, however, remains a long way off, warn the researchers: 'drugs or other treatments aimed at the filaggrin gene are still some years away but this work is a major step in the right direction and should give hope to those with these distressing conditions'.

SOURCES & REFERENCES
Genetic defect could lead to improved eczema and allergy treatment
Nursing Times |  7 April 2009
'Major step' in allergic work
Press Association |  7 April 2009
Mouse gene aids allergy research
BBC News Online |  6 April 2009
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
8 February 2016 - by Kulraj Singh Bhangra 
Scientists have identified a genetic mutation that causes a rare inherited allergy to vibration...
29 July 2013 - by David O'Rourke 
Mutations in a single genetic pathway known to be disrupted in those with connective tissue disorders have been shown to be a major factor causing allergies in humans...
3 October 2011 - by Luciana Strait 
Inheriting two copies of a genetic variant has been associated with reduced response to steroid inhalers in people with asthma. The finding could explain why around 40 percent people with asthma do not benefit from inhaled steroids, the most commonly prescribed medication for the condition....
27 September 2010 - by Ken Hanscombe 
A new study queries the role of allergy in the development of asthma, and suggests that a different disease process is involved in childhood and adult-onset asthma. Asthma is a complex condition with genetic and environmental factors, although experts believe it has a strong heritable component....
20 March 2006 - by BioNews 
Scientists working on an inherited skin disorder have identified the mutated gene involved, a discovery which they say will help shed light on eczema, and some cases of asthma. The study, published in the journal Nature Genetics, shows that people affected by the condition ichthyosis vulgaris have a faulty version...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.